Works matching DE "TEMOZOLOMIDE"

Results: 1701

Glioblastoma multiforme: an updated overview of temozolomide resistance mechanisms and strategies to overcome resistance.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02567-3

By:

Pu, Jianlin;
Yuan, Kai;
Tao, Jian;
Qin, Yuliang;
Li, Yongxin;
Fu, Jing;
Li, Zhong;
Zhou, Haimei;
Tang, Zhengxiu;
Li, Li;
Gai, Xuesong;
Qin, Dongdong

Publication type:

Article

Butterfly glioblastoma: trends in therapeutic modalities, extent of resection and survival in the temozolomide era. a SEER-based study.

Published in:

Neurosurgical Review, 2025, v. 48, n. 1, p. 1, doi. 10.1007/s10143-025-03558-2

By:

Laviv, Yosef;
Kasper, Ekkehard M.

Publication type:

Article

Therapeutic efficacy to dose-dependent toxicity of Cabazitaxel in C6-induced glioblastoma model of rats.

Published in:

Toxicology Research, 2025, v. 14, n. 2, p. 1, doi. 10.1093/toxres/tfaf048

By:

Mohammadzadeh, Zahra;
Khaksari, Mohammad;
Nematollahi, Mohammad Hadi;
Kheirandish, Reza;
Moslemizadeh, Amirhossein;
Delshad, Sina;
Faramarz, Sanaz;
Tezerji, Sara Sheibani;
Torkashvand, Mohammad;
Shahba, Samira;
Bashiri, Hamideh

Publication type:

Article

Chemotherapy in pediatric low-grade gliomas (PLGG).

Published in:

Child's Nervous System, 2024, v. 40, n. 10, p. 3229, doi. 10.1007/s00381-024-06458-w

By:

Lassaletta, Alvaro;
Zapotocky, Michal;
Bouffet, Eric

Publication type:

Article

Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma.

Published in:

Child's Nervous System, 2024, v. 40, n. 6, p. 1671, doi. 10.1007/s00381-024-06329-4

By:

Özkan, Ayşe;
Yağcı Küpeli, Begül;
Küpeli, Serhan;
Sezgin, Gülay;
Bayram, İbrahim

Publication type:

Article

A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors.

Published in:

Child's Nervous System, 2022, v. 38, n. 5, p. 919, doi. 10.1007/s00381-022-05479-7

By:

Metts, Jonathan;
Harrington, Brittany;
Salman, Emad;
Bradfield, Scott M.;
Flanary, Jennifer;
Mosha, Maua;
Amankwah, Ernest;
Stapleton, Stacie

Publication type:

Article

Selenium enhances TRPA1 channel-mediated activity of temozolomide in SH-SY5Y neuroblastoma cells.

Published in:

Child's Nervous System, 2020, v. 36, n. 6, p. 1283, doi. 10.1007/s00381-020-04567-w

By:

Özkal, Birol;
Övey, İshak Suat

Publication type:

Article

Patterns of care and survival outcomes in patients with astroblastoma: an individual patient data analysis of 152 cases.

Published in:

Child's Nervous System, 2017, v. 33, n. 8, p. 1295, doi. 10.1007/s00381-017-3410-5

By:

Mallick, Supriya;
Benson, Rony;
Venkatesulu, Bhanuprasad;
Melgandi, Wineeta;
Rath, Goura

Publication type:

Article

High-grade glioma in children and adolescents: a single-center experience.

Published in:

Child's Nervous System, 2016, v. 32, n. 2, p. 291, doi. 10.1007/s00381-015-2980-3

By:

Yazici, Gozde;
Zorlu, Faruk;
Cengiz, Mustafa;
Ozyigit, Gokhan;
Eren, Gulnihan;
Yüce, Deniz;
Varan, Ali;
Akyuz, Canan;
Akalan, Nejat;
Gurkaynak, Murat

Publication type:

Article

Primary cerebral histiocytic sarcoma in childhood: a case report of protracted survival and review of the literature.

Published in:

Child's Nervous System, 2015, v. 31, n. 12, p. 2363, doi. 10.1007/s00381-015-2815-2

By:

Foster, Mitchell;
Kamaly-Asl, Ian;
Stivaros, Stavros;
Kelsey, Anna;
Gattamenini, Rao;
Kilday, John-Paul

Publication type:

Article

Pediatric gliosarcoma treated with adjuvant radiotherapy and temozolomide.

Published in:

Child's Nervous System, 2015, v. 31, n. 12, p. 2341, doi. 10.1007/s00381-015-2919-8

By:

Mallick, Supriya;
Gandhi, Ajeet;
Sharma, Daya;
Gupta, Subhash;
Haresh, Kunhi;
Rath, Goura;
Julka, Pramod

Publication type:

Article

Cranial and spinal oligodendrogliomatosis: a case report and review of the literature.

Published in:

Child's Nervous System, 2015, v. 31, n. 1, p. 147, doi. 10.1007/s00381-014-2506-4

By:

Lee, Siang;
Wong, Albert;
Stadler, James;
McClendon, Jamal;
Smith, Timothy;
Wadhwani, Nitin;
Tomita, Tadanori

Publication type:

Article

Mechanisms of Sensitivity of Soft Tissue Sarcoma Cells to Temozolomide.

Published in:

Bulletin of Experimental Biology & Medicine, 2017, v. 163, n. 2, p. 260, doi. 10.1007/s10517-017-3779-x

By:

Khusnutdinov, R.;
Boichuk, S.

Publication type:

Article

Treatment of Poorly Differentiated Glioma Using a Combination of Monoclonal Antibodies to Extracellular Connexin-43 Fragment, Temozolomide, and Radiotherapy.

Published in:

Bulletin of Experimental Biology & Medicine, 2014, v. 157, n. 4, p. 510, doi. 10.1007/s10517-014-2603-0

By:

Yusubalieva, G.;
Baklaushev, V.;
Gurina, O.;
Zorkina, Ya.;
Gubskii, I.;
Kobyakov, G.;
Golanov, A.;
Goryainov, S.;
Gorlachev, G.;
Konovalov, A.;
Potapov, A.;
Chekhonin, V.

Publication type:

Article

Combination of Cisplatin and Temozolomide versus Carboplatin and Etoposide in the Treatment of Recurrent High Grade Glioma Patients.

Published in:

Zagazig University Medical Journal, 2024, v. 30, n. 1, p. 34, doi. 10.21608/ZUMJ.2022.143246.2579

By:

Elwan, Amira;
Embaby, Ahmed;
Bakry, Adel S.

Publication type:

Article

A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy.

Published in:

Discover Oncology, 2023, v. 14, n. 1, p. 1, doi. 10.1007/s12672-023-00818-9

By:

Wan, Yanzhi;
Li, Guangqi;
Deng, Junyue;
Zhu, Hong;
Ma, Xuelei

Publication type:

Article

A MRI-based radiomics model for predicting the response to anlotinb combined with temozolomide in recurrent malignant glioma patients.

Published in:

Discover Oncology, 2023, v. 14, n. 1, p. 1, doi. 10.1007/s12672-023-00751-x

By:

Li, Yurong;
Xu, Weilin;
Fei, Yinjiao;
Wu, Mengxing;
Yuan, Jinling;
Qiu, Lei;
Zhang, Yumeng;
Chen, Guanhua;
Cheng, Yu;
Cao, Yuandong;
Zhou, Shu

Publication type:

Article

Hypermutated phenotype in gliosarcoma of the spinal cord.

Published in:

NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00143-w

By:

Hong, Christopher S.;
Kuzmik, Gregory A.;
Kundishora, Adam J.;
Elsamadicy, Aladine A.;
Koo, Andrew B.;
McGuone, Declan;
Blondin, Nicholas A.;
DiLuna, Michael L.;
Erson-Omay, E. Zeynep

Publication type:

Article

Temozolomide Nonresponsiveness in Aggressive Prolactinomas and Carcinomas: Management and Outcomes.

Published in:

Journal of the Endocrine Society, 2022, v. 6, n. 2, p. 1, doi. 10.1210/jendso/bvab190

By:

Das, Liza;
Rai, Ashutosh;
Salunke, Pravin;
Ahuja, Chirag Kamal;
Sood, Ashwani;
Radotra, Bishan Dass;
Sood, Ridhi;
Korbonits, Márta;
Dutta, Pinaki

Publication type:

Article

Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma.

Published in:

Journal of the Endocrine Society, 2021, v. 5, n. 10, p. 1, doi. 10.1210/jendso/bvab133

By:

Lin, Andrew L;
Tabar, Viviane;
Young, Robert J;
Cohen, Marc;
Cuaron, John;
Yang, T Jonathan;
Rosenblum, Marc;
Rudneva, Vasilisa A;
Geer, Eliza B;
Bodei, Lisa

Publication type:

Article

Long-Term Use of Temozolomide as Safe and Effective Therapy for an Aggressive Corticotroph Adenoma in a Very Old Patient.

Published in:

Journal of the Endocrine Society, 2021, v. 5, n. 8, p. 1, doi. 10.1210/jendso/bvab065

By:

Decaroli, Maria Chiara;
Ansaloni, Anna;
Monzani, Maria Laura;
Losa, Marco;
Zunarelli, Elena;
Rochira, Vincenzo;
Madeo, Bruno

Publication type:

Article

MGMT Promoter Methylation and Parathyroid Carcinoma.

Published in:

Journal of the Endocrine Society, 2019, v. 3, n. 11, p. 2114, doi. 10.1210/js.2019-00175

By:

Storvall, Sara;
Ryhänen, Eeva;
Heiskanen, Ilkka;
Vesterinen, Tiina;
Bensch, Frank V;
Schildt, Jukka;
Kytölä, Soili;
Karhu, Auli;
Arola, Johanna;
Schalin-Jäntti, Camilla

Publication type:

Article

Investigation of Atmospheric Pressure Plasma Jet Effects on the Treatment of Glioblastoma Using PET Imaging.

Published in:

Frontiers in Biomedical Technologies, 2022, v. 9, n. 3, p. 224, doi. 10.18502/fbt.v9i3.9649

By:

Ramazani, Mahdieh Bakhtiari;
Yahaghi, Effat;
Nohekhan, Morteza

Publication type:

Article

Silencing lncRNA LINC01410 suppresses cell viability yet promotes apoptosis and sensitivity to temozolomide in glioblastoma cells by inactivating PTEN/AKT pathway via targeting miR-370-3p.

Published in:

Immunopharmacology & Immunotoxicology, 2021, v. 43, n. 6, p. 680, doi. 10.1080/08923973.2021.1966031

By:

Fu, Tingkai;
Yang, Yunxue;
Mu, Zhenxin;
Sun, Rongwei;
Li, Xingang;
Dong, Jun

Publication type:

Article

IDH1-mutant metabolite D-2-hydroxyglutarate inhibits proliferation and sensitizes glioma to temozolomide via down-regulating ITGB4/PI3K/AKT.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02088-y

By:

Tong, Shuangmei;
Wu, Jian;
Song, Yun;
Fu, Wenhuan;
Yuan, Yifan;
Zhong, Pin;
Liu, Yinlong;
Wang, Bin

Publication type:

Article

The combination of temozolomide and perifosine synergistically inhibit glioblastoma by impeding DNA repair and inducing apoptosis.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02085-1

By:

Zhao, Wenpeng;
Zhou, Liwei;
Zhao, Wentao;
Yang, Huiying;
Lu, Zhenwei;
Zhang, Liang;
Zhang, Yaya;
Xie, Yuanyuan;
Lu, Hanwen;
Han, Wanhong;
He, Jiawei;
Qiu, Xiansheng;
Jia, Fang;
Zhao, Wujie;
Zhang, Bingchang;
Wang, Zhanxiang

Publication type:

Article

STING activation increases the efficiency of temozolomide in PTEN harbouring glioblastoma cells.

Published in:

Turkish Journal of Medical Sciences, 2024, v. 54, n. 3, p. 607, doi. 10.55730/1300-0144.5828

By:

YILDIRIM, Zafer;
DOĞAN, Eda;
GÜLER KARA, Hale;
KOSOVA, Buket;
BOZOK, Vildan

Publication type:

Article

Cassane-type diterpenes from Caesalpinia minax induce apoptosis in pituitary adenoma: structure–activity relationship, ER stress and Wnt/β-catenin pathways.

Published in:

Journal of Asian Natural Products Research, 2017, v. 19, n. 5, p. 423, doi. 10.1080/10286020.2016.1217520

By:

Li, Zong-Yang;
Li, Qing-Zhong;
Ma, Guo-Xu;
Chen, Lei;
Zhang, Ce;
Chen, Bao-dong;
Yang, Jun-Shan;
Li, Wei-Ping

Publication type:

Article

Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8.

Published in:

Journal of Extracellular Vesicles, 2018, v. 7, n. 1, p. 1, doi. 10.1080/20013078.2018.1446660

By:

Berenguer, Jordi;
Lagerweij, Tonny;
Zhao, Xi Wen;
Dusoswa, Sophie;
van der Stoop, Petra;
Westerman, Bart;
Gooijer, Mark C. de;
Zoetemelk, Marloes;
Zomer, Anoek;
Crommentuijn, Matheus H. W.;
Wedekind, Laurine E.;
López-López, Àlan;
Giovanazzi, Alberta;
Bruch-Oms, Marina;
Meulen-Muileman, Ida H. van der;
Reijmers, Rogier M.;
van Kuppevelt, Toin H.;
García-Vallejo, Juan-Jesús;
van Kooyk, Yvette;
Tannous, Bakhos A.

Publication type:

Article

Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study.

Published in:

Immunity, Inflammation & Disease, 2020, v. 8, n. 3, p. 342, doi. 10.1002/iid3.315

By:

Rahman, Mohummad A.;
Brekke, Jorunn;
Arnesen, Victoria;
Hannisdal, Marianne H.;
Navarro, Andrea G.;
Waha, Andreas;
Herfindal, Lars;
Rygh, Cecilie B.;
Bratland, Eirik;
Brandal, Petter;
Haasz, Judit;
Oltedal, Leif;
Miletic, Hrvoje;
Lundervold, Arvid;
Lie, Stein A.;
Goplen, Dorota;
Chekenya, Martha

Publication type:

Article

Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells.

Published in:

BioMed Research International, 2019, p. 1, doi. 10.1155/2019/2710693

By:

Zhu, Zhiyuan;
Zhang, Pingde;
Li, Ning;
Kiang, Karrie Mei Yee;
Cheng, Stephen Yin;
Wong, Vincent Kam-Wai;
Leung, Gilberto Ka-Kit

Publication type:

Article

Glioblastoma Treatment with Temozolomide and Bevacizumab and Overall Survival in a Rural Tertiary Healthcare Practice.

Published in:

BioMed Research International, 2018, p. 1, doi. 10.1155/2018/6204676

By:

Carter, Tonia C.;
Medina-Flores, Rafael;
Lawler, Benjamin E.

Publication type:

Article

Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent.

Published in:

BioMed Research International, 2018, p. 1, doi. 10.1155/2018/6501508

By:

Dong, Qian;
He, Lin;
Chen, Linbo;
Deng, Qiongzhen

Publication type:

Article

Knockdown of BCL6 Inhibited Malignant Phenotype and Enhanced Sensitivity of Glioblastoma Cells to TMZ through AKT Pathway.

Published in:

BioMed Research International, 2018, p. 1, doi. 10.1155/2018/6953506

By:

Song, Wen;
Wang, Zhenling;
Kan, Pengcheng;
Ma, Zhuolin;
Wang, Yaru;
Wu, Qiaoli;
Yao, Xiuhua;
Zhang, Biao

Publication type:

Article

Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas.

Published in:

Cancer Biology & Medicine, 2023, v. 20, n. 5, p. 325, doi. 10.20892/j.issn.2095-3941.2022.0761

By:

Chun Wang;
Qiushi Li;
Jian Xiao;
Yang Liu

Publication type:

Article

Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1.

Published in:

Experimental Dermatology, 2017, v. 26, n. 7, p. 598, doi. 10.1111/exd.13372

By:

Niessner, Heike;
Kosnopfel, Corinna;
Sinnberg, Tobias;
Beck, Daniela;
Krieg, Kathrin;
Wanke, Ines;
Lasithiotakis, Konstantinos;
Bonin, Michael;
Garbe, Claus;
Meier, Friedegund

Publication type:

Article

The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-53684-y

By:

Oraiopoulou, Mariam-Eleni;
Tzamali, Eleftheria;
Psycharakis, Stylianos E.;
Tzedakis, Georgios;
Makatounakis, Takis;
Manolitsi, Katina;
Drakos, Elias;
Vakis, Antonis F.;
Zacharakis, Giannis;
Papamatheakis, Joseph;
Sakkalis, Vangelis

Publication type:

Article

Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48777-z

By:

Zhu, Songxian;
Guo, Jingjing;
Yu, Li;
Liu, Jun;
Chen, Jixiang;
Xin, Jinxin;
Zhang, Yuqiang;
Luo, Jie;
Duan, Chao

Publication type:

Article

Coixendide efficacy in combination with temozolomide in glioblastoma and transcriptome analysis of the mechanism.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41421-w

By:

Zhao, Zhenran;
Zhang, Lei;
Zhang, Xiaohan;
Yue, Yong;
Liu, Shengchen;
Li, Yanan;
Ban, Xiang;
Jin, Peng;
Zhao, Cuizhu

Publication type:

Article

SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis.

Published in:

Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2017.00960

By:

Dai, Shuang;
Yan, Yuanliang;
Xu, Zhijie;
Zeng, Shuangshuang;
Qian, Long;
Huo, Lei;
Li, Xuejun;
Sun, Lunquan;
Gong, Zhicheng

Publication type:

Article

Immune Checkpoint in Glioblastoma: Promising and Challenging.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00242

By:

Jing Huang;
Fangkun Liu;
Zhixiong Liu;
Hui Tang;
Haishan Wu;
Qianni Gong;
Jindong Chen

Publication type:

Article

Adjuvant Temozolomide.

Published in:: Journal of Oncology Navigation & Survivorship, 2016, v. 7, n. 7, p. 58
Publication type:: Article

Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole‐trimethoprim and temozolomide.

Published in:

Nephrology, 2021, v. 26, n. 1, p. 12, doi. 10.1111/nep.13783

By:

Athavale, Akshay;
Morris, Jack;
Jardine, Meg;
Gallagher, Martin;
Sen, Shaundeep;
Ritchie, Angus;
Wang, Amanda Y.

Publication type:

Article

Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness.

Published in:

Oncogene, 2015, v. 34, n. 14, p. 1853, doi. 10.1038/onc.2014.92

By:

Bandey, I;
Chiou, S-H;
Huang, A-P;
Tsai, J-C;
Tu, P-h

Publication type:

Article

Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults.

Published in:

Cancer Research & Treatment, 2022, v. 54, n. 2, p. 563, doi. 10.4143/crt.2021.178

By:

Hee Young Ju;
Meerim Park;
Jun Ah Lee;
Hyeon Jin Park;
Seog Yun Park;
June Hyuk Kim;
Hyun Guy Kang;
Hee Chul Yang;
Byung-Kiu Park

Publication type:

Article

Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study).

Published in:

Cancer Research & Treatment, 2022, v. 54, n. 2, p. 396, doi. 10.4143/crt.2021.393

By:

Ahn, Grace S.;
Kihwan Hwang;
Tae Min Kim;
Chul Kee Park;
Jong Hee Chang;
Tae-Young Jung;
Jin Hee Kim;
Do-Hyun Nam;
Se-Hyuk Kim;
Heon Yoo;
Yong-Kil Hong;
Eun-Young Kim;
Dong-Eun Lee;
Jungnam Joo;
Yu Jung Kim;
Gheeyoung Choe;
Byung Se Choi;
Seok-Gu Kang;
Jeong Hoon Kim;
Chae-Yong Kim

Publication type:

Article

Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma.

Published in:

Cancer Research & Treatment, 2021, v. 53, n. 2, p. 367, doi. 10.4143/crt.2020.506

By:

Lin Lin;
Jinquan Cai;
Zixiao Tan;
Xiangqi Meng;
Ruiyan Li;
Yang Li;
Chuanlu Jiang

Publication type:

Article

Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study).

Published in:

Cancer Research & Treatment, 2020, v. 52, n. 2, p. 505, doi. 10.4143/crt.2019.421

By:

Kihwan Hwang;
Tae Min Kim;
Chul-Kee Park;
Jong Hee Chang;
Tae-Young Jung;
Jin Hee Kim;
Do-Hyun Nam;
Se-Hyuk Kim;
Heon Yoo;
Yong-Kil Hong;
Eun-Young Kim;
Dong-Eun Lee;
Jungnam Joo;
Yu Jung Kim;
Gheeyoung Choe;
Byung Se Choi;
Seok-Gu Kang;
Jeong Hoon Kim;
Chae-Yong Kim

Publication type:

Article

Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.

Published in:

Cancer Research & Treatment, 2017, v. 49, n. 2, p. 387, doi. 10.4143/crt.2016.106

By:

Young-Bem Se;
Seung Hyun Kim;
Ji Young Kim;
Ja Eun Kim;
Yun-Sik Dho;
Jin Wook Kim;
Yong Hwy Kim;
Hyun Goo Woo;
Se-Hyuk Kim;
Shin-Hyuk Kang;
Hak Jae Kim;
Tae Min Kim;
Soon-Tae Lee;
Seung Hong Choi;
Sung-Hye Park;
Il Han Kim;
Dong Gyu Kim;
Chul-Kee Park

Publication type:

Article

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.

Published in:

Cancer Research & Treatment, 2017, v. 49, n. 1, p. 193, doi. 10.4143/crt.2015.473

By:

Byung Sup Kim;
Ho Jun Seo;
Do-Hyun Nam;
Chul-Kee Park;
Il Han Kim;
Tae Min Kim;
Jeong Hoon Kim;
Young Hyun Cho;
Sang Min Yoon;
Jong Hee Chang;
Seok-Gu Kang;
Eui Hyun Kim;
Chang-Ok Suh;
Tae-Young Jung;
Kyung-Hwa Lee;
Chae-Yong Kim;
In Ah Kim;
Chang-Ki Hong;
Heon Yoo;
Jin Hee Kim

Publication type:

Article